Literature DB >> 22100558

Quantification of bioactive sphingo- and glycerophospholipid species by electrospray ionization tandem mass spectrometry in blood.

Gerhard Liebisch1, Max Scherer.   

Abstract

Bioactive glycerophospho- and sphingolipids species are involved in the regulation of numerous biological processes and implicated in the pathophysiology of various diseases. Here we review electrospray ionization tandem mass spectrometric (ESI-MS/MS) methods for the analysis of these bioactive lipid species in blood including lysophosphatidic acid (LPA), lysophosphatidylcholine (LPC), bis(monoacylglycero)phosphate (BMP), ceramide (Cer), sphingosine-1-phosphate (S1P) and sphingosylphosphorylcholine (SPC). Beside direct tandem mass spectrometric and liquid chromatography coupled approaches, we present an overview of concentrations of these bioactive lipids in plasma. The analytical strategies are discussed together with aspects of sample preparation, quantification and sample stability.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100558     DOI: 10.1016/j.jchromb.2011.10.037

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Measurement of Lysophosphatidic Acid and Sphingosine-1-Phosphate by Liquid Chromatography-Coupled Electrospray Ionization Tandem Mass Spectrometry.

Authors:  Maria P Kraemer; Suchismita Halder; Susan S Smyth; Andrew J Morris
Journal:  Methods Mol Biol       Date:  2018

Review 2.  Applications of mass spectrometry for cellular lipid analysis.

Authors:  Chunyan Wang; Miao Wang; Xianlin Han
Journal:  Mol Biosyst       Date:  2015-01-19

3.  Challenges in accurate quantitation of lysophosphatidic acids in human biofluids.

Authors:  Joelle M Onorato; Petia Shipkova; Anne Minnich; Anne-Françoise Aubry; John Easter; Adrienne Tymiak
Journal:  J Lipid Res       Date:  2014-05-28       Impact factor: 5.922

Review 4.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

5.  Determination of oxidized phosphatidylcholines by hydrophilic interaction liquid chromatography coupled to Fourier transform mass spectrometry.

Authors:  Pia Sala; Sandra Pötz; Martina Brunner; Martin Trötzmüller; Alexander Fauland; Alexander Triebl; Jürgen Hartler; Ernst Lankmayr; Harald C Köfeler
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

6.  Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.

Authors:  Emmanuel Eroume-A Egom; Ross Fitzgerald; Rebecca Canning; Rebabonye B Pharithi; Colin Murphy; Vincent Maher
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

7.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis.

Authors:  Susanne Feder; Reiner Wiest; Thomas S Weiss; Charalampos Aslanidis; Doris Schacherer; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Lipids Health Dis       Date:  2021-01-18       Impact factor: 3.876

8.  Quantitation of phosphatidic acid and lysophosphatidic acid molecular species using hydrophilic interaction liquid chromatography coupled to electrospray ionization high resolution mass spectrometry.

Authors:  Alexander Triebl; Martin Trötzmüller; Anita Eberl; Pia Hanel; Jürgen Hartler; Harald C Köfeler
Journal:  J Chromatogr A       Date:  2014-04-28       Impact factor: 4.759

Review 9.  Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside.

Authors:  Yan Xu
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.